| Patents for C12R 1 - Micro-organisms (92,025) |
|---|
| 02/16/1993 | US5187091 Bacillus thuringiensis cryiiic gene encoding toxic to coleopteran insects |
| 02/16/1993 | US5187089 Variants wherein there are nonpolar amino acid substitutions at the substrate binding site |
| 02/16/1993 | US5187087 Recominbant herpesvirus of turkeys and live vector vaccines derived thereof |
| 02/16/1993 | US5187086 Molecules with antibody combining sites that catalyze hydrolysis reactions through use of a charged hapten |
| 02/16/1993 | US5187081 Culturing endothia in a fermentation medium, separating cells from medium, concentrating medium, isolating protease and coproduced polysacchardie and hydrolyzing polysaccharide in the presence of an enzyme |
| 02/16/1993 | US5187078 DNA segment as vector for gene expression in microorganisms or animal cells |
| 02/16/1993 | US5187077 Leukaemia inhibitory factor |
| 02/16/1993 | US5187075 Cloning and expression of a variant gene of platelet factor 4 and compositions thereof to modulate immune responses |
| 02/16/1993 | US5186933 Synthesis and immunogenicity of rotavirus genes using a baculovirus expression system |
| 02/16/1993 | CA1313635C Copolymer production |
| 02/16/1993 | CA1313634C Strains of yeast for the expression of heterologous genes |
| 02/14/1993 | CA2075423A1 Rapid method for detection of methicillin resistant staphylococci |
| 02/10/1993 | EP0527061A1 Composition derived from a succinoglycan, process for obtaining the same and its uses |
| 02/10/1993 | EP0526953A1 Multichain polypeptides or proteins and processes for their production |
| 02/10/1993 | EP0526952A2 Soluble interleukin-2 receptor as a disease indicator and a method of assaying the same |
| 02/10/1993 | EP0526935A1 New microorganism for producing C-31 desmethyl FR-900520 cyclic hemiketal |
| 02/10/1993 | EP0526934A1 New C-31 desmethyl FR-900520 cyclic hemiketal immunosuppressant agent |
| 02/10/1993 | EP0526926A2 Gellan gum for non-brittle gels |
| 02/10/1993 | EP0526906A1 Process for producing 3-deacylated derivatives of a 16-membered macrolide antibiotic, microorganism to be used therefor and novel macrolide antibiotic |
| 02/10/1993 | EP0526905A2 Multimers of the soluble forms of TNF receptors, their preparation and pharmaceutical compositions containing them |
| 02/10/1993 | EP0526888A2 Monoclonal antibody reactive with human pancreas cancer tissue |
| 02/10/1993 | EP0526850A2 Copolymer and method for production thereof |
| 02/10/1993 | EP0526584A1 A method for enriching fetal cells from maternal blood |
| 02/10/1993 | EP0526452A1 Hybrid immunoglobulins |
| 02/10/1993 | EP0402415B1 Synthetic scm-active cancer recognition peptides |
| 02/10/1993 | EP0396563B1 Chimeric glycoproteins containing immunogenic segments of the glycoproteins of human respiratory syncytial virus |
| 02/10/1993 | CA2075560A1 Deacetylase genes for the production of phosphinothricin or phosphinothricyl-alanyl-alanine, processes of their isolation, and their use |
| 02/09/1993 | US5185441 Polypeptides that bind to CD2, the receptor on the surface of T-cells |
| 02/09/1993 | US5185432 Monoclonal antibodies and antigen for human non-small cell lung carcinoma and other certain human carcinomas |
| 02/09/1993 | US5185257 Thermostable xanthine oxidase from Arthrobacter luteus |
| 02/09/1993 | US5185254 Gene family of tumor-associated antigens |
| 02/09/1993 | US5185252 Enzymic oxidation of fatty acids on a porous bed solid support |
| 02/09/1993 | US5185242 Method for lysing mycobacteria using achromopeptidase |
| 02/09/1993 | US5185148 Applying bioinsecticide |
| 02/09/1993 | CA1313490C Keratinocyte megacolonies and assays for growth factors |
| 02/07/1993 | CA2075343A1 Monoclonal antibody and uses of the same |
| 02/04/1993 | WO1993002358A1 Method of diagnosing ovarian and endometrial cancer with monoclonal antibodies oxa and oxb |
| 02/04/1993 | WO1993002206A1 Purification of recombinant ciliary neurotrophic factor and c-terminal truncated ciliary neurotrophic factor and methods for treating peripheral nerve damage |
| 02/04/1993 | WO1993002203A1 Fr901451 substance, process for preparation thereof and use thereof |
| 02/04/1993 | WO1993002201A1 Nucleotide sequences and resistance proteins cycloheximide |
| 02/04/1993 | WO1993002199A1 Novel type of gram positive replicon and construction of recombinant vectors containing same |
| 02/04/1993 | WO1993002194A1 Production of polyalkanoate |
| 02/04/1993 | WO1993002192A1 Modified pf4 compositions and methods of use |
| 02/04/1993 | WO1993002191A1 Humanized antibody against cd18 |
| 02/04/1993 | WO1993002190A1 Production of antibodies |
| 02/04/1993 | WO1993002188A1 Universal donor cells |
| 02/04/1993 | WO1993002186A1 Bacterial esterase for cocaine detection |
| 02/04/1993 | WO1993002184A1 Papilloma virus vaccine |
| 02/04/1993 | WO1993002108A1 Recombinant antibodies for human therapy |
| 02/04/1993 | WO1993002097A1 Protein v: a novel igg binding factor |
| 02/04/1993 | WO1993002083A1 Hatching agent for the potato cyst nematode |
| 02/04/1993 | WO1993002034A1 Process for enzymatically preparing enantiomer-free esters and alcohols |
| 02/04/1993 | WO1993001833A1 Improved vaccine |
| 02/04/1993 | DE4224050A1 Loesliche kit-liganden Soluble kit ligand |
| 02/04/1993 | DE4222416A1 Monoclonal antibody specific for prostatic acid phosphatase - shows very little cross-reactivity with phosphatase(s) from platelets, erythrocytes or leukocytes, for prostatic cancer diagnosis |
| 02/04/1993 | DE4122599A1 Oberflaechen-expressionsvektor zum screenen von antikoerpern A roughness expression vector for antibody screening |
| 02/04/1993 | CA2113993A1 Protein v: a novel igg binding factor |
| 02/04/1993 | CA2113815A1 Purification of recombinant ciliary neurotrophic factor and c-terminal truncated ciliary neurotrophic factor and methods for treating peripheral nerve damage |
| 02/04/1993 | CA2113801A1 Method of diagnosing ovarian and endometrial cancer with monoclonal antibodies oxa and oxb |
| 02/04/1993 | CA2113572A1 Improved vaccine |
| 02/04/1993 | CA2113206A1 Modified pf4 compositions and methods of use |
| 02/04/1993 | CA2111858A1 Production of antibodies |
| 02/04/1993 | CA2111711A1 Process for enzymatically preparing enantiomer-free esters and alcohols |
| 02/03/1993 | EP0526258A2 A87689 Compounds, their production and use as phospholipase-A2 inhibitors |
| 02/03/1993 | EP0526150A1 Assay |
| 02/03/1993 | EP0525861A1 Process for the enzymatic preparation of 7-amino-cephalosporanic acids |
| 02/03/1993 | EP0525846A1 Sporomiella intermedia and processes therefrom |
| 02/03/1993 | EP0525836A2 Assay method using novel NAD synthetase |
| 02/03/1993 | EP0525828A2 Recombinant polypeptides and their uses, including assay for aids virus |
| 02/03/1993 | EP0525588A2 Production of pradimicin antibiotics by actinomadura strain |
| 02/03/1993 | EP0525479A1 Spicamycin derivatives and the use thereof |
| 02/03/1993 | EP0525145A1 Process for producing ergolin derivatives |
| 02/03/1993 | EP0525083A1 Erythromycin derivatives |
| 02/03/1993 | EP0525076A1 Recombinant bile salt activated lipases |
| 02/03/1993 | EP0233915B1 Molecular farming |
| 02/03/1993 | CN1068501A A-c-b proinsulin, method of manufacturing and using same, and intermediates in insulin production |
| 02/02/1993 | US5183826 Antiviral agent |
| 02/02/1993 | US5183755 Anti-human papillomavirus monoclonal antibody, hybridoma producing the same and process for preparing the same |
| 02/02/1993 | US5183753 Preparation of xylanase by cultivating thermomyces lanuginosus dsm 5826 in a medium containing corn cobs |
| 02/02/1993 | US5183747 Culturing from streptomyces, chromatographic isolation; nucleotides; for analyzing, cleaving DNA sequences |
| 02/02/1993 | US5183739 Hybridoma which produces antibody binds to an epitope on glycohemoglobin comprising epsilon-d-fructosyllysine is useful for diagnosis of diseases |
| 02/02/1993 | US5183734 Antibodies, diagnostic systems and methods for assaying SV40 HBxAg |
| 02/02/1993 | US5183667 Treating tumor disease by administering culture product containing beta-glucan |
| 02/02/1993 | US5183659 Protection of equines against Streptococcus equi |
| 02/02/1993 | US5183658 A pathogen of hemorrhagic fever with renal syndrome; strain from human body is injected to one-day old mouse, raised to ten days, paralyzing and cutting head apart of rat to take brain, purification, inactivation and addition of adjuvant |
| 02/02/1993 | CA2092571A1 Ribozyme inhibition of bcr-abl gene expression |
| 02/02/1993 | CA2075163A1 A87689 compounds |
| 02/02/1993 | CA2074861A1 Microorganism for producing c-31 desmethyl fr-900520 cyclic hemiketal immunosuppressant agent |
| 02/02/1993 | CA2074856A1 C-31 desmethyl fr-900520 cyclic hemiketal immunosuppressant agent |
| 02/02/1993 | CA1313360C Lipolytic enzymes and their use in detergent compositions |
| 02/01/1993 | CA2071140A1 Production of pradimicin antibiotics by fermentation |
| 01/27/1993 | EP0524906A1 DNA coding for prolylendopeptidase |
| 01/27/1993 | EP0524899A1 Recombinant DNA molecules coding for the VB2 T cell receptor, method of preparation, antibodies and medicaments containing them |
| 01/27/1993 | EP0524832A2 Activator gene for macrolide biosynthesis |
| 01/27/1993 | EP0524808A2 In situ PCR preparations, their use, and corresponding thermal cycler equipment |
| 01/27/1993 | EP0524687A1 A process for the glycosylation of avermectin compounds at the 14a-position |
| 01/27/1993 | EP0524686A1 A process for the 14a-hydroxylation of avermectin compounds |
| 01/27/1993 | EP0524672A1 CCV vaccine |
| 01/27/1993 | EP0524671A1 Novel culture of exserohilum rostratum and processes therefrom |
| 01/27/1993 | EP0524604A2 Process for the preparations of S-(+)-2,2-dimethyl-cyclopropane carboxamid by genetically engineered microorganismes |